#101: TheMachine: Amgen Receives Executive Summary from Independent Cochrane Collaboration Review of ESAs in Oncology
Amgen Inc., (NASDAQ: AMGN) announced it has received a summary of
... |
September 30, 2008
09:37:05 PM |
#100: NewsBot: Amgen Announces Voting Results of Annual Meeting of Stockholders
Amgen (NASDAQ:AMGN), today announced results of voting at the company’s
... |
May 9, 2008
06:21:24 PM |
#99: TheMachine: Amgen's Oncology Pipeline Data Highlighted at Upcoming Scientific Meeting
Five Investigational Compounds from Robust Ongoing Clinical Trials
... |
April 8, 2008
02:30:13 AM |
#97: FastFun: Pivotal Phase 3 NPLATE(TM) Study in Non-Splenectomized Patients Met Primary Endpoints and Out of the Gate: Celgene Falls
--(www.USEquityNews.com)-- 12/11/2007 - Pharmaceutical industry alert... |
December 12, 2007
10:15:51 PM |
#96: FastFun: Pivotal Phase 3 NPLATE(TM) Study in Non-Splenectomized Patients Met Primary Endpoints
Data Also Shows Potential of Nplate as a Long-term Treatment Option for... |
December 10, 2007
10:05:55 PM |
#95: FastFun: Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets Primary Endpoints
Data Show Romiplostim Increased and Sustained Platelet Counts in... |
December 10, 2007
10:05:13 PM |
#94: FastFun: Amgen in Discussions with FDA to Update U.S. Prescribing Information for ESAs
Revised ESA Labeling to be Based on New Data from PREPARE and GOG... |
December 7, 2007
08:25:04 PM |
#93: FastFun: Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
Clinically Relevant Biomarker Provides Physicians With the Ability to... |
December 7, 2007
08:24:06 PM |
#92: FastFun: Amgen Announces Interim Results of Aranesp(R) ''PREPARE'' Study in Breast Cancer Patients
Amgen, Inc. (NASDAQ: AMGN) today announced that it had received interim... |
December 7, 2007
08:16:56 PM |
#91: FastFun: Amgen Hires Former Clinton Aide to Lobby and Gilead Seeks Aztreonam Lysine Approval
--(www.USEquityNews.com)-- 11/19/2007 - Pharmaceutical industry alert... |
November 26, 2007
08:31:13 PM |
#90: FastFun: Gilead Sciences CEO Exercises Options and Genzyme Rises After Icahn Buys Shares
--(www.USEquityNews.com)-- 11/16/2007 - Pharmaceutical industry alert... |
November 26, 2007
08:28:20 PM |
#89: NewsBot: AMGN News Amgen to Present at the Lehman Brothers Tenth Annual Global Healthcare Conference
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ:AMGN) will participate in... |
March 19, 2007
09:43:00 AM |
#88: NewsBot: AMGN News Amgen to Present at the 27th Annual Cowen & Company Health Care Conference
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ:AMGN) will participate in... |
March 12, 2007
11:53:00 AM |
#87: NewsBot: AMGN News Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ:AMGN) today announced the... |
March 9, 2007
10:07:00 AM |
#86: NewsBot: AMGN News Prime Minister Tony Blair Opens Major Amgen Development Centre in London
UXBRIDGE, England--(BUSINESS WIRE)--Amgen (NASDAQ:AMGN) announced today that the... |
March 2, 2007
03:30:00 AM |
| 
| 
| 
| 
| 
| 
